von Tobias Borgers | Feb 11, 2020 | Glaxo
The company announced that these changes are a result of its transformation plan, which will see GSK split its consumer healthcare business from its core operations.According to the company, the ‘new GSK’ that will be formed following that separation will see it focus...
von Tobias Borgers | Feb 6, 2020 | Merck
Merck & Co., Inc. (NYSE:MRK) Shares Sold by Birmingham Capital Management Co. Inc. AL Slater Sentinel Link zum Originalbeitrag
von Tobias Borgers | Jan 6, 2020 | Boehringer
Industry Analysis Global contract manufacturing market is set to witness a substantial CAGR in the forecast period of 2019- 2026. The report contains data of the base year 2018 and historic year 2017. The growth of the market can be attributed to the increasing...
von Tobias Borgers | Dez 31, 2019 | Sanofi
Kann ein Herz wirklich brechen? Frankfurt, 29. Mai 2018 – Clemens Kaiser, Vorsitzender der Geschäftsführung von Sanofi in Deutschland eröffnete heute im Herzen Berlins den Sanofi-Gesundheits-Showroom im Beisein von Boris Velter, Staatssekretär in der Senatsverwaltung...
von Tobias Borgers | Dez 30, 2019 | Sanofi
Sanofi unterstützt 19 innovative Forschungsprojekte mit neuem europäischem akademischem Förderprogramm Das Sanofi Innovations-Programm in Europa soll die Etablierung neuer früher Forschungsansätze unterstützen, die innovative akademische Forschung schnell in die...
von Tobias Borgers | Dez 1, 2019 | Roche
Media Release Basel, 04 September 2019 Roche to present pivotal data for satralizumab in neuromyelitis optica spectrum disorder and six-year OCREVUS data in multiple sclerosis at ECTRIMS Investigational medicine satralizumab significantly reduces the risk of relapse...
